Exenatide and lixisenatide are exendin based GLP-1 receptor agonists
The first couple of weeks, nothing dramatic happened
Other observed findings are represented by round nucleated cells often with a targetoid appearance throughout the epidermis (corresponding to dyskeratotic keratinocytes), intraepidermal hyperreflective dendritic, spindle-shaped cells (corresponding to Langerhans cells at immunostaining), and plump bright cells in the papillary dermis (corresponding to melanophages).2,79 It must be highlighted that the dendritic cells may represent a confounder finding as they may also correspond to atypical melanocytes and could lead to the wrong diagnosis of melanoma,9 and that the differential diagnosis of melanophages with pigmented cells of Bowens disease may not be easy due to the epidermis disruption and tumor cell heavy pigmentation
The retatrutide complete guide and retatrutide dosing information provide detailed coverage
Some treatment plans start with a repletion phase and then move to maintenance dosing
95% CI 0.45, 0.68), but not in the USA (RR 0.93